Evaluation of Tests Performance on a New Digital Orthoptic Platform
ESPPADON
Evaluation de la Performance d'Une Nouvelle Plateforme de Tests de dépistage Orthoptique numériques
1 other identifier
observational
96
1 country
1
Brief Summary
This clinical trials aims to evaluate Tests Performance on a New Digital Orthoptic Platform.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2015
CompletedFirst Posted
Study publicly available on registry
January 11, 2016
CompletedStudy Start
First participant enrolled
February 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2016
CompletedApril 14, 2017
April 1, 2017
7 months
December 29, 2015
April 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of Ocular Convergence as Measured by the Two Machines
through study completion, an average of 1 hour
Eligibility Criteria
People performing an orthoptic exam at ophthalmology department of Brest University Hospital.
You may qualify if:
- Patients with less than or equal to 16 ocular deviation prism diopters, without or with slight amblyopia (maximum difference of 2 logarithmic visual acuity lines) and performing an orthoptic exam at ophthalmology department of Brest University Hospital.
You may not qualify if:
- monophthalmic
- Medium and deep amblyopic patients
- Patients with not normal ocular motility
- Patient who underwent surgery at the head and neck during the previous three months
- Children under 7 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Brest
Brest, 29609, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Béatrice Cochener, Pr
University Hospital of Brest
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2015
First Posted
January 11, 2016
Study Start
February 18, 2016
Primary Completion
September 29, 2016
Study Completion
September 29, 2016
Last Updated
April 14, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share